Business ❯ Pharmaceuticals ❯ Biotechnology

Drug Development

Acquisitions Obesity Treatments Clinical Trials Molecular Glue Degraders Bispecific Antibodies Clinical Research RNA Technology Blood Coagulation Treatments Monte Rosa Therapeutics Artificial Intelligence Rare Diseases Market Access Collaboration Agreements Evotec SE Regulatory Affairs Collaboration

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

The company is targeting an FDA IND in 2027 contingent on supportive preclinical data.

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

Takeda and Nabla Bio Expand AI Protein-Design Deal With Potential Payouts Above $1 Billion

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet